SL

Sanjaysingh Laljiwan Bhaskar

Active Director Designated Partner DIN 10504296
DIN 10504296 First appointment Feb 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sanjaysingh Laljiwan Bhaskar

Data last updated:

Sanjaysingh Laljiwan Bhaskar is a Designated Partner at Sarva Kalyanum Healthcare Llp (since 2024).

DIN 10504296
Primary Designation Designated Partner
First Appointment 12 Feb 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner12 Feb 20242024Active

Board colleagues of Sanjaysingh Laljiwan Bhaskar

Directorship timeline

Open interactive timeline →
Sarva Kalyanum Healthcare Llp
Premium access

Shareholding and investment profile for Sanjaysingh Laljiwan Bhaskar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjaysingh Laljiwan Bhaskar

Sanjaysingh Laljiwan Bhaskar currently holds 1 directorship: Sarva Kalyanum Healthcare Llp (Designated Partner, since 12 Feb 2024).

Sanjaysingh Laljiwan Bhaskar was first appointed on 12 Feb 2024 as Designated Partner at Sarva Kalyanum Healthcare Llp.

The current boards of Sanjaysingh Laljiwan Bhaskar's companies include Dilip Madhukar Ramole (Sarva Kalyanum Healthcare Llp), Nilesh Shrikant Upadhyay (Sarva Kalyanum Healthcare Llp), Pankaj Ashok Kasar (Sarva Kalyanum Healthcare Llp), Raghunath Murlidhar Khade (Sarva Kalyanum Healthcare Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available